Keyphrases
Peroxisome Biogenesis
100%
High-content Screening
100%
Type 2 Diabetes Mellitus (T2DM)
75%
Metabolic Syndrome
52%
Human Cells
37%
Peroxisome
37%
Metabolic Types
35%
Fatty Acid Oxidation
35%
High Content
34%
Image-based Screening
29%
Non-adipose Tissue
29%
Plasma Fatty Acids
29%
High-content Assay
29%
Peroxisomal Disorders
29%
Assay Development
26%
Production Facilities
22%
Chemical Probes
22%
Molecular Library
22%
Metabolism
22%
Lipotoxicity
14%
Long-chain Fatty Acid Oxidation
14%
Addition Compounds
14%
Fatty Liver
14%
Secondary Assays
14%
Lipid Accumulation
14%
Long-chain Polyunsaturated Fatty Acids (LC-PUFA)
14%
Ectopic Lipid Accumulation
14%
Valuable Chemicals
14%
Therapeutic Avenues
14%
PPAR Activation
14%
Screening Center
14%
Peroxisomal Biogenesis
14%
Novel Therapeutics
14%
Therapeutic Potential
11%
Risk Factors
11%
Metabolic Disorders
11%
Fatty Acids
11%
Insulin Resistance
11%
Liver
11%
Cell Culture
11%
Diabetic
11%
Rodents
11%
Hyperglycemia
11%
Gene Expression Profiling
11%
Peroxisomal
11%
Distinct Mechanism
11%
Compound Screening
6%
Syndrome Type
6%
Orthogonal Assay
6%
Biochemistry, Genetics and Molecular Biology
Peroxisome
75%
Biogenesis
75%
Beta Oxidation
20%
Fatty Acid Blood Level
16%
Lipid Storage
12%
Metabolic Pathway
12%
Molecular Library
12%
Animal Model
12%
Very Long Chain Fatty Acid
8%
Lipotoxicity
8%
Peroxisome Proliferator-Activated Receptor
6%
Insulin Resistance
6%
Hyperglycemia
6%
Cell Culture
6%
Metabolic Disorder
6%
Gene Expression Profiling
6%
Translating (Language)
6%
Immunology and Microbiology
Biogenesis
75%
Peroxisome
75%
Fatty Acid Oxidation
20%
Human Cell
20%
Fatty Acid Blood Level
16%
Lipid Storage
12%
Molecular Library
12%
Adipose Tissue
12%
Cell Culture
6%
Blood Plasma
6%
Insulin Resistance
6%
Gene Expression Profiling
6%